MRD Testing Market Report: Trends, Forecast and Competitive Analysis to 2031

The future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 with a CAGR of 11.7% from 2025 to 2031. The major drivers for this market are increasing occurrence of blood-related cancers, growing global elderly population, and progress in technology for minimal residual disease (MRD)
According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 from $1.6 billion in 2024, at a CAGR of 11.7% from 2025 to 2031. The major drivers for this market are increasing occurrence of blood-related cancers, growing global elderly population, and progress in technology for minimal residual disease (MRD) testing.

A more than 150-page report to understand trends, opportunity and forecast in MRD testing market to 2031 by technology (flow cytometry, polymerase chain reaction (PCR), next-generation sequencing (NGS), and others), application (hematological malignancies, leukemia, lymphoma, solid tumors, and others), end use industry (hospitals and specialty clinics, diagnostic laboratories, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Lucintel forecasts that Polymerase Chain Reaction (PCR) is expected to witness highest growth over the forecast period.

Within this market, hospitals and specialty clinics will remain the largest segment.

Download sample by clicking on MRD testing market

APAC is expected to witness highest growth over the forecast period.

Labcorp, F. Hoffmann-La Roche, Guardant Health, Sysmex Corporation, Neogenomics Laboratories, Adaptive Biotechnologies Corporation, Archerdx, Asuragen, Arup Laboratories are the major suppliers in the MRD testing market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact: Roy Almaguer Lucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com Tel. +1-972-636-5056

Explore Our Latest Publications

Hi-Fi System Market [https://www.lucintel.com/hi-fi-system-market.aspx]

Bearing for Mechanical and Electrical Product [https://www.lucintel.com/bearing-for-mechanical-and-electrical-product-market.aspx]

Telecom Electronic Manufacturing Service Market [https://www.lucintel.com/telecom-electronic-manufacturing-service-market.aspx]

Timing Device Market [https://www.lucintel.com/timing-device-market.aspx]

Visual Inspection Microscope Market [https://www.lucintel.com/visual-inspection-microscope-market.aspx]

Construction Waste Crusher Market

Media Contact
Company Name: Lucintel
Contact Person: Roy Almaguer
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=mrd-testing-market-report-trends-forecast-and-competitive-analysis-to-2031]
Phone: 972.636.5056
Address:8951 Cypress Waters Blvd., Suite 160
City: Dallas
State: TEXAS
Country: United States
Website: https://www.lucintel.com/mrd-testing-market.aspx

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.